Tara S Abraham

Tara S Abraham

UNVERIFIED PROFILE

Are you Tara S Abraham?   Register this Author

Register author
Tara S Abraham

Tara S Abraham

Publications by authors named "Tara S Abraham"

Are you Tara S Abraham?   Register this Author

10Publications

687Reads

24Profile Views

Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients.

J Immunother Cancer 2019 Apr 23;7(1):104. Epub 2019 Apr 23.

Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, 1020 Locust Street, JAH 368, Philadelphia, PA, 19107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-019-0576-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477737PMC
April 2019

TCR Retrogenic Mice as a Model To Map Self-Tolerance Mechanisms to the Cancer Mucosa Antigen GUCY2C.

J Immunol 2019 02 14;202(4):1301-1310. Epub 2019 Jan 14.

Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA 19107

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1801206DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363846PMC
February 2019

The swinging pendulum of cancer immunotherapy personalization.

Per Med 2017 05 5;14(3):259-270. Epub 2017 May 5.

Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson University, 1020 Locust Street Philadelphia, PA 19107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pme-2016-0108DOI Listing
May 2017

GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity.

Oncoimmunology 2016 2;5(10):e1227897. Epub 2016 Sep 2.

Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University , Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/2162402X.2016.1
Publisher Site
http://dx.doi.org/10.1080/2162402X.2016.1227897DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087292PMC
September 2016

Economic burden of dermatologic adverse events induced by molecularly targeted cancer agents.

Arch Dermatol 2011 Dec;147(12):1403-9

Department of Dermatology, SERIES Clinic, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archdermatol.2011.719DOI Listing
December 2011